14/02/2019

ESTEVE APPOINTS JORDI MUNTAÑOLA AS CHIEF COMMERCIAL OFFICER FOR EUROPE

Jordi Muntañola will take on the leadership of all the pharmaceutical activities in Spain and Europe

ESTEVE has appointed Jordi Muntañola as the new Chief Commercial Officer for Europe, taking on the leadership of all the pharmaceutical activities in Spain and Europe. Dr. Muntañola takes over from Joe Sullivan, who remains at the company for a few months facilitating a smooth transition.
Born in 1978 in Barcelona, Jordi Muntañola holds a PhD in Molecular Biology from the University of Navarra and an MBA from ESADE. He has broad experience in the healthcare sector at companies such as the Werfen Group and Esaote, among others. Throughout his career, Dr. Muntañola has formed part of and managed teams of R&D, Corporate Strategy, Business Development, Operations and Business Management, and has headed Business Transformation projects in Spain as well as internationally.
Jordi Muntañola joined ESTEVE’s team in 2016 as Director of Pharma Operational Excellence, a responsibility to which, at a later stage, the Management of the Consumer Care Division was added.

Last news

  • POMPEU FABRA UNIVERSITY AND ESTEVE ARE TO INVESTIGATE NEW TARGETS FOR TREATING NEUROPATHIC PAIN

    The RIBOPAIN project aims to identify new therapeutic solutions for pain and to develop more effective drugs

    read more
  • ESTEVE ANNOUNCES A RESTRUCTURING OF ITS PHARMACEUTICAL ACTIVITY

    Esteve Pharmaceuticals submits a reduction in force (RIF) which will affect 103 jobs in Spain

    read more
  • NURSES OFFER CARE AND PREVENTION OF DRY EYE, A CONDITION THAT AFFECTS 60% OF PEOPLE OLDER THAN 45 YEARS

    Dry eye care and prevention is a pending issue in the Spanish society and a source of great concern for specific patients, such as those admitted to Intensive Care Units.

    The longer time...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.